Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night

Journal:

Cell Metabolism

Published:

2026-01-12

DOI:

10.1016/j.cmet.2025.12.004

Affiliations:

8

Authors:

21

Go to article

Institutions	Authors	Share
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), United Kingdom (UK)	6.900000	0.33
Churchill Hospital, United Kingdom (UK)	6.900000	0.33
The University of Melbourne (UniMelb), Australia	3.000000	0.14
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK)	2.633333	0.13
John Radcliffe Hospital, United Kingdom (UK)	1.033333	0.05
University of Bristol (UoB), United Kingdom (UK)	0.333333	0.02
University of Oxford, United Kingdom (UK)	0.200000	0.01

Interested in Zoology?